Translational Research Unit Visits Fellowship
Application deadline: 1 April 2019
Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates.
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
An annual Congress providing a comprehensive overview of all the practice-changing new data. Register now!
The ESMO-MCBS scale is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Veronika Ballová explains how this attractive and interactive book gives a complete overview of what is essential in the rapidly moving field of leukaemia and myeloma. Veronika Ballová is co-editor of the ESMO Leukaemia and Myeloma: Essentials for Clinicians and a member of the ESMO Publishing Working Group.
20 Mar 2019
Approval is based on results from the IMpower133 study
20 Mar 2019
Françoise Mornex is first female recipient of Heine H. Hansen Award
18 Mar 2019
It is recommended for use as an option for treatment of adults with diffuse large B-cell lymphoma after 2 or more systemic therapies
14 Mar 2019
Tumour specific splicing presents a large new class of splicing associated potential neoantigens
13 Mar 2019
ESMO would like to thank Dr. Gustavo A. López for his help in translating into Spanish.
13 Mar 2019
Findings from GINECO case-control study
Sao Paulo, Brazil
22 Mar
- 24 Mar
2019
Geneva, Switzerland
10 Apr
- 13 Apr
2019
Prague, Czech Republic
12 Apr
- 13 Apr
2019
Hong Kong
13 Apr
- 14 Apr
2019
Lugano, Switzerland
26 Apr
- 27 Apr
2019
Berlin, Germany
02 May
- 04 May
2019
